Factor VII deficiency: do all need replacement for cardiac surgery?

Abstract

In cardiac surgery, supplementation with recombinant factor VIIa is the treatment of choice for patients with factor VII deficiency, but overzealous administration can be associated with thromboembolic side-effects. A 53-year-old man with factor VII activity 15.2%, international normalized ratio 2.9, and acute thrombotic critical coronary anatomy, underwent coronary artery bypass surgery and a thoracotomy with decortication 5 months later. He was managed successfully without recombinant factor VIIa supplementation. This case demonstrates that current bedside and laboratory tests such as thromboelastography, prothrombin time or international normalized ratio, and factor VII activity may not predict replacement therapy in these patients.

Keywords

Blood coagulation Coronary artery bypass Factor VIIa Pleural effusion Recombinant proteins Thrombelastography

Get full access to this article

View all access options for this article.

References

Aledort

. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VII inhibitor bypass activity. J Thrombosis and hemostasis 2004; 2: 1700–1708.

Giansily-Bliazot

Schved

. Potential predictors of bleeding risk in inherited factor VII deficiency. Clinical, biological and molecular criteria. Thromb Hemostat 2005; 94: 901–906.

Society of Thoracic Surgeons Blood Conservation Guideline Task Force

Ferraris

Brown

et al.

2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944–982.

Gill

Herbertson

Vuylsteke

et al.

Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009; 120: 21–27.

Diprose

Herbertson

O’Shaughnessy

Gill

. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005; 95: 596–602.

Giansily-Blaizot

Verdier

Biron-Adréani

et al.

Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?

Haematologica 2004; 89: 704–709.

Frattini

Bonfanti

Piccoli

et al.

Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report. Haemophilia 2013; 19: e268–e269.

Rosenthal

Volk, Spies

Ziemer

Holinski

Von Heymann

. Successful coronary artery bypass surgery in severe congenital factor VII deficiency: perioperative treatment with factor VII concentrate. Thromb Haemost 2007; 98: 900–902.